FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery
Proceedings of the National Academy of Sciences · 07.03.2023 · 120 (10)
DOI: 10.1073/pnas.2216722120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 27.02.2023. Verfasst von Mohammad Zulkifli und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843. Hauptthemen laut MEDLINE: Copper, Electron Transport Complex IV. Die Arbeit wurde bisher 179-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Recent studies have uncovered the therapeutic potential of elesclomol (ES), a copper-ionophore, for copper deficiency disorders. However, we currently do not understand the mechanism by which copper brought into cells as ES–Cu(II) is released and delivered to cuproenzymes present in different subcellular compartments. Here, we have utilized a combination of genetic, biochemical, and cell-biological approaches to demonstrate that intracellular release of copper from ES occurs inside and outside of mitochondria. The mitochondrial matrix reductase, FDX1, catalyzes the reduction of ES–Cu(II) to Cu(I), releasing it into mitochondria where it is bioavailable for the metalation of mitochondrial cuproenzyme— cytochrome c oxidase. Consistently, ES fails to rescue cytochrome c oxidase abundance and activity in copper-deficient cells lacking FDX1. In the absence of FDX1, the ES-dependent increase in cellular copper is attenuated but not abolished. Thus, ES-mediated copper delivery to nonmitochondrial cuproproteins continues even in the absence of FDX1, suggesting alternate mechanism(s) of copper release. Importantly, we demonstrate that this mechanism of copper transport by ES is distinct from other clinically used copper-transporting drugs. Our study uncovers a unique mode of intracellular copper delivery by ES and may further aid in repurposing this anticancer drug for copper deficiency disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843.
- Department of Chemistry, Texas A&M University, College Station, TX 77842.
- Department of Chemistry, University of Houston, Houston, TX 77204.
- Advanced Photon Source, Argonne National Laboratory, Argonne, IL 60439.
- Department of Biochemistry, Life Sciences Center, University of Missouri, Columbia, MO 65211.
- Department of Ophthalmology, Life Sciences Center, University of Missouri, Columbia, MO 65211.
ORCID-Profile: Mohammad Zulkifli, Yuteng Zhang, Shivatheja Soma, Trung Le, Tai-Yen Chen, Martina Ralle, David P Barondeau, Vishal M Gohil
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- HHS | NIH | National Institute of General Medical Sciences
- HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases
- HHS | NIH | National Cancer Institute
Zitieren
APA
Zulkifli, M., Spelbring, A. N., Zhang, Y., Soma, S., Chen, S., Li, L., Le, T., Shanbhag, V., Petris, M. J., Chen, T. Y., Ralle, M., Barondeau, D. P., & Gohil, V. M. (2023). FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery. Proceedings of the National Academy of Sciences, 120(10). https://doi.org/10.1073/pnas.2216722120
Vancouver
Zulkifli M, Spelbring AN, Zhang Y, Soma S, Chen S, Li L, et al. FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery. Proceedings of the National Academy of Sciences. 2023;120(10). doi:10.1073/pnas.2216722120
BibTeX
@article{Zulkifli2023,
author = {Zulkifli, Mohammad and Spelbring, Amy N and Zhang, Yuteng and Soma, Shivatheja and Chen, Si and Li, Luxi and Le, Trung and Shanbhag, Vinit and Petris, Michael J and Chen, Tai-Yen and Ralle, Martina and Barondeau, David P and Gohil, Vishal M},
title = {FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {10},
doi = {10.1073/pnas.2216722120}
}
EUVIMED